develops and markets applications to enhance bioavailability of drugs.
The company’s product Transported Prodrug uses transporter genomics, assay technology, and proprietary chemistries to introduce therapeutic molecules into cells.
Additionally, it provides solution to improve expiring drugs.
XenoPort was founded in 1999 and is headquartered in Santa Clara, California.
